Pharma-Bio Serv, Inc. financial data

Symbol
PBSV on OTC
Industry
Services-Management Consulting Services
Location
Industrial Zone Street 1, Lot 14, Dorado, Puerto Rico
Fiscal year end
October 31
Former names
LAWRENCE CONSULTING GROUP INC (to 2/28/2006)
Latest financial report
10-Q - Q2 2024 - Sep 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 711 % -21%
Debt-to-equity 25 % +1.63%
Return On Equity -5.81 % -162%
Return On Assets -4.65 % -162%
Operating Margin -11 % -248%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23M shares -0.02%
Common Stock, Shares, Outstanding 23M shares -0.03%
Entity Public Float 13.6M USD +10.5%
Common Stock, Value, Issued 2.35K USD +0.04%
Weighted Average Number of Shares Outstanding, Basic 23M shares -0.02%
Weighted Average Number of Shares Outstanding, Diluted 23M shares -0.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.8M USD -40.2%
Cost of Revenue 8.05M USD -36.9%
Operating Income (Loss) -1.19M USD -189%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -788K USD -140%
Income Tax Expense (Benefit) 52.4K USD -88%
Net Income (Loss) Attributable to Parent -841K USD -155%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.87M USD -79.8%
Marketable Securities, Current 6.34M USD -45.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2.6M USD -43.9%
Assets, Current 15.9M USD -19.2%
Property, Plant and Equipment, Net 18.2K USD -56.5%
Operating Lease, Right-of-Use Asset 239K USD -39.3%
Other Assets, Noncurrent 126K USD
Assets 16.3M USD -19.6%
Accounts Payable, Current 1.33M USD
Liabilities, Current 1.9M USD -22.5%
Accrued Income Taxes, Noncurrent 1.43M USD
Operating Lease, Liability, Noncurrent 71.4K USD -69.4%
Liabilities 2.63M USD -36%
Accumulated Other Comprehensive Income (Loss), Net of Tax 253K USD +14.2%
Retained Earnings (Accumulated Deficit) 12.3M USD -17.2%
Stockholders' Equity Attributable to Parent 13.7M USD -15.4%
Liabilities and Equity 16.3M USD -19.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -337K USD -118%
Net Cash Provided by (Used in) Financing Activities -1.73M USD +1.45%
Net Cash Provided by (Used in) Investing Activities 5.79M USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 23.5M shares +0.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.65M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.52M USD +127%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 347K USD -28.9%
Payments to Acquire Property, Plant, and Equipment 1.15K USD -94.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -809K USD -147%
Lessee, Operating Lease, Liability, to be Paid 379K USD -31.6%
Property, Plant and Equipment, Gross 668K USD +1.07%
Operating Lease, Liability, Current 162K USD +8.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 175K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 175K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.1K USD -51.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.1K USD -83.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 175K USD 0%
Additional Paid in Capital 1.64M USD +2.82%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 54K USD -16.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%